These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23477943)

  • 1. Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists-serotonin reuptake transporter inhibitors for the treatment of depression.
    Wu YJ; He H; Bertekap R; Westphal R; Lelas S; Newton A; Wallace T; Taber M; Davis C; Macor JE; Bronson J
    Bioorg Med Chem; 2013 Apr; 21(8):2217-2228. PubMed ID: 23477943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a cyclopentylamine as an orally active dual NK1 receptor antagonist-serotonin reuptake transporter inhibitor.
    Wu YJ; He H; Gao Q; Wu D; Bertekap R; Westphal RS; Lelas S; Newton A; Wallace T; Taber M; Davis C; Macor JE; Bronson J
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1611-4. PubMed ID: 24507922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the gerbil forced swim test.
    Lelas S; Li YW; Wallace-Boone TL; Taber MT; Newton AE; Pieschl RL; Davis CD; Molski TF; Newberry KS; Parker MF; Gillman KW; Bronson JJ; Macor JE; Lodge NJ
    Neuropharmacology; 2013 Oct; 73():232-40. PubMed ID: 23770339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biaryls as potent, tunable dual neurokinin 1 receptor antagonists and serotonin transporter inhibitors.
    Degnan AP; Tora GO; Han Y; Rajamani R; Bertekap R; Krause R; Davis CD; Hu J; Morgan D; Taylor SJ; Krause K; Li YW; Mattson G; Cunningham MA; Taber MT; Lodge NJ; Bronson JJ; Gillman KW; Macor JE
    Bioorg Med Chem Lett; 2015 Aug; 25(15):3039-43. PubMed ID: 26048800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Indazoles as Potent, Orally Active Dual Neurokinin 1 Receptor Antagonists and Serotonin Transporter Inhibitors for the Treatment of Depression.
    Degnan AP; Tora GO; Huang H; Conlon DA; Davis CD; Hanumegowda UM; Hou X; Hsiao Y; Hu J; Krause R; Li YW; Newton AE; Pieschl RL; Raybon J; Rosner T; Sun JH; Taber MT; Taylor SJ; Wong MK; Zhang H; Lodge NJ; Bronson JJ; Macor JE; Gillman KW
    ACS Chem Neurosci; 2016 Dec; 7(12):1635-1640. PubMed ID: 27744678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First dual NK(1) antagonists-serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants.
    Ryckmans T; Balançon L; Berton O; Genicot C; Lamberty Y; Lallemand B; Pasau P; Pirlot N; Quéré L; Talaga P
    Bioorg Med Chem Lett; 2002 Jan; 12(2):261-4. PubMed ID: 11755367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
    Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
    J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate.
    Di Fabio R; Alvaro G; Braggio S; Carletti R; Gerrard PA; Griffante C; Marchioro C; Pozzan A; Melotto S; Poffe A; Piccoli L; Ratti E; Tranquillini E; Trower M; Spada S; Corsi M
    Bioorg Med Chem; 2013 Nov; 21(21):6264-73. PubMed ID: 24075145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors.
    Tamiz AP; Zhang J; Flippen-Anderson JL; Zhang M; Johnson KM; Deschaux O; Tella S; Kozikowski AP
    J Med Chem; 2000 Mar; 43(6):1215-22. PubMed ID: 10737754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and systematic evaluation of 4-arylpiperazine- and 4-benzylpiperidine napthyl ethers as inhibitors of monoamine neurotransmitters reuptake.
    Paudel S; Min X; Acharya S; Khadka DB; Yoon G; Kim KM; Cheon SH
    Bioorg Med Chem; 2018 Nov; 26(20):5538-5546. PubMed ID: 30293797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further structure-activity relationship studies of piperidine-based monoamine transporter inhibitors: effects of piperidine ring stereochemistry on potency. Identification of norepinephrine transporter selective ligands and broad-spectrum transporter inhibitors.
    He R; Kurome T; Giberson KM; Johnson KM; Kozikowski AP
    J Med Chem; 2005 Dec; 48(25):7970-9. PubMed ID: 16335921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors.
    Nencetti S; Mazzoni MR; Ortore G; Lapucci A; Giuntini J; Orlandini E; Banti I; Nuti E; Lucacchini A; Giannaccini G; Rossello A
    Eur J Med Chem; 2011 Mar; 46(3):825-34. PubMed ID: 21272963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test.
    Chenu F; Guiard BP; Bourin M; Gardier AM
    Behav Brain Res; 2006 Sep; 172(2):256-63. PubMed ID: 16806519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists.
    Schöppe J; Ehrenmann J; Klenk C; Rucktooa P; Schütz M; Doré AS; Plückthun A
    Nat Commun; 2019 Jan; 10(1):17. PubMed ID: 30604743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
    Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
    J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 5-HT
    Canale V; Partyka A; Kurczab R; Krawczyk M; Kos T; Satała G; Kubica B; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Popik P; Zajdel P
    Bioorg Med Chem; 2017 May; 25(10):2789-2799. PubMed ID: 28391970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT(1A) antagonist component into a class of serotonin reuptake inhibitors.
    Mewshaw RE; Meagher KL; Zhou P; Zhou D; Shi X; Scerni R; Smith D; Schechter LE; Andree TH
    Bioorg Med Chem Lett; 2002 Feb; 12(3):307-10. PubMed ID: 11814784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5.
    Takeuchi K; Kohn TJ; Honigschmidt NA; Rocco VP; Spinazze PG; Hemrick-Luecke SK; Thompson LK; Evans DC; Rasmussen K; Koger D; Lodge D; Martin LJ; Shaw J; Threlkeld PG; Wong DT
    Bioorg Med Chem Lett; 2006 May; 16(9):2347-51. PubMed ID: 16298130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of DSP-1053, a novel benzylpiperidine derivative with potent serotonin transporter inhibitory activity and partial 5-HT
    Yoshinaga H; Nishida T; Sasaki I; Kato T; Oki H; Yabuuchi K; Toyoda T
    Bioorg Med Chem; 2018 May; 26(8):1614-1627. PubMed ID: 29456112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of SMP-304, a novel benzylpiperidine derivative with serotonin transporter inhibitory activity and 5-HT
    Yoshinaga H; Masumoto S; Koyama K; Kinomura N; Matsumoto Y; Kato T; Baba S; Matsumoto K; Horisawa T; Oki H; Yabuuchi K; Kodo T
    Bioorg Med Chem; 2017 Jan; 25(1):293-304. PubMed ID: 27865645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.